Press releases

BrainCheck Closes $8M Series A Funding Round, Empowers Physicians with a Better Way to Assess Cognitive Impairment & Dementia


HOUSTON (BUSINESS WIRE) — OCTOBER 09, 2019

BrainCheck, a cognitive healthcare platform built for physicians, today announced an $8 million Series A funding round co-led by S3 Ventures and Tensility Venture Partners.

Additional investors in the round include True Wealth Ventures and Nueterra Capital, bringing the cumulative amount of funding raised by BrainCheck to $11 million. The funds will be deployed toward marketing and business development initiatives targeted at expanding BrainCheck’s utilization amongst physician groups as well as into the enterprise healthcare market.

READ MORE

BrainCheck will also utilize the new injection of venture capital toward research and development by personalizing its algorithm for an improved overall patient experience. The company is on a mission to bridge the growing accessibility gap between the 50 million seniors in the United States versus only 12,000 neurologists.

BrainCheck is transforming cognitive healthcare by replacing outdated pencil-and-paper brain health tests with research-backed digital solutions that are faster and more efficient. This allows organizations to track patients over time, reduces testing bias and improves outcomes. BrainCheck includes artificial intelligence functionality to compare data sets, improving accuracy and empowering primary care physicians to confidently make diagnoses and create personalized treatment plans.

“Cognitive healthcare should be an end-to-end solution where problems can be assessed early, and results shared between patients and physicians,” said Dr. Yael Katz, co-founder and CEO of BrainCheck. “By analyzing multiple forms of data, BrainCheck helps physicians create and fine-tune personalized interventions. This not only improves outcomes for current patients, but is invaluable to developing management and treatment strategies for future generations.”

Improving Dementia Patient Outcomes

BrainCheck is a digital platform that uses simple tests administered from an iPhone, iPad or desktop computer to interpret a patient’s current level of cognitive function and create a personalized treatment plan. Unlike older cognitive tests that are onerous to conduct, BrainCheck enables doctors to test, diagnose and create a personalized treatment plan for patients rapidly and reliably. The platform also utilizes AI to compare each patient’s test results with a multi-modal data set, where traditional computerized tests analyze only the individual’s responses.

“To date, more than 100,000 individuals are using BrainCheck to monitor their cognitive health, and this is only the beginning,” said David Eagleman, co-founder and chief science officer of BrainCheck. “We’re providing a platform for patients, caregivers, and physicians to work together to manage one of the biggest public health crises of our time.”

Investor Perspectives on BrainCheck Series A Funding Round

“BrainCheck has demonstrated rapid growth combined with extremely high rates of customer satisfaction,” said Charlie Plauche, partner at S3 Ventures who will be joining the board in conjunction with the financing. “S3 Ventures is thrilled that our investment will accelerate the adoption of BrainCheck’s comprehensive cognitive health solution by physicians everywhere and will help the company evolve into a mainstay in the enterprise health sector.”

“One of the biggest challenges in cognitive neuroscience is early detection of impairment,” said Armando Pauker, co-founder of Tensility Venture Partners and co-lead Investor. “Innovation depends on being able to leverage large datasets to identify subtle deviations both within and between individuals. Tensility Ventures’ investment is a testament to BrainCheck’s ability to identify these patterns and use this intelligence to improve patient diagnosis, prognosis and care.”

“As healthcare operators, we know that change in healthcare is hard to implement,” said Kevin Standefer, Strategic Investor at Nueterra Capital. “This device provides an operational efficiency to physician practices by enabling them to get the right care to patients sooner. Nueterra’s investment in this product reflects the real-world value that BrainCheck is providing clinicians.”

“New guidelines pertaining to the evaluation and treatment of cognitive impairment have created a need for new technologies,” said Kerry Rupp, General Partner at True Wealth Ventures. “BrainCheck identified and capitalized on this opportunity by creating a scalable solution that effectively addressed this need. True Wealth Ventures is proud to have been a part of BrainCheck’s success thus far and we’re thrilled to watch this company continue to succeed as they expand into new markets and grow their teams in Houston and Austin.”

About BrainCheck

BrainCheck provides rapid, mobile cognitive assessment and decision support technology to physicians, empowering them to deliver high-quality, personalized cognitive health care to patients everywhere and get reimbursed. This helps patients live better and safer lives at home, decreases caregiver frustration, and saves health systems trillions. Founded in 2015 by neuroscientists and technologists Dr. David Eagleman (Baylor College of Medicine / Stanford) and Dr. Yael Katz, BrainCheck helps lessen the human and economic toll of cognitive impairment and dementia through its interactive cognitive assessment and care management technology. BrainCheck is used in over 200 clinical practices and by 100,000 people around the world to detect cognitive changes early and enable patients, caregivers, and clinicians to work together to implement personalized recommendations to preserve brain health and functional independence. BrainCheck enables physicians to get paid for cognitive care management (via Medicare reimbursement) and simultaneously reduces healthcare costs by keeping patients healthy, safe, and out of the hospital. To learn more, please visit braincheck.com.

BrainCheck Care Empowers Physicians to Deliver Advanced Cognitive Healthcare at Scale, a Much Needed Win for Dementia Patients and Caregivers


BrainCheck adds clinical decision support and cognitive care management technology to its cognitive assessment platform

HOUSTON (PRWEB) — JULY 24, 2018
As digital medicine continues to transform patient care, BrainCheck launched its digital, reimbursable cognitive care management technology, BrainCheck Care, at the 2018 Alzheimer’s Association International Conference in Chicago. This end-to-end solution is the first of its kind and allows physicians to deliver personalized recommendations to help improve outcomes and prolong independence for people with dementia and cognitive impairment. With the addition of cognitive care management technology to BrainCheck’s popular cognitive testing platform, physicians now have a full suite of tools to help assess and effectively manage cognitive impairment, facilitating meaningful conversations with patients and their caregivers..

READ MORE

The digital platform incorporates a wide range of screening tools and streamlined workflows to collect patient and caregiver inputs. By combining these disparate components with its clinical decision support algorithms, BrainCheck Care helps the physician provide a treatment plan tailored to the patient’s needs.

New dementia research such as the FINGER study demonstrates the benefits of early detection and management, leading to several big changes in the last year. The American Academy of Neurology (AAN) updated its practice guideline for mild cognitive impairment (MCI), which recommends that physicians use a validated assessment tool in primary care as well as track the patient’s cognitive status once impairment has been diagnosed.

The Centers for Medicare and Medicaid Services (CMS) established CPT code 99483, which allows clinicians to be reimbursed for providing care planning services to people with cognitive impairment. And the Alzheimer’s Association created new initiatives to educate doctors about taking a leading role in dementia care.

BrainCheck Care comes on the heels of these changes, providing technology to make it easy for physicians to adhere to the updated guideline, and take advantage of the new reimbursement code and cost savings associated with cognitive care management.

“We help physicians deliver personalized cognitive care at scale and grow their bottom line, providing a win for patients, physicians, and health systems,” said Dr. Yael Katz, co-founder and CEO of BrainCheck. “By making it easy to gather all the required inputs with one simple platform, we are bringing to life the mission of the Alzheimer’s Association to accelerate the adoption of cognitive care planning by physicians.”

To celebrate the release of BrainCheck Care, the company hosted a special launch event on Monday, July 23, 2018, at the Marriott Marquis Chicago. BrainCheck co-founder and New York Times bestselling author, Dr. David Eagleman, along with a panel of industry experts, discussed the benefits of providing care planning services to cognitively impaired individuals. Stop by BrainCheck booth #329 to learn how reimbursable cognitive care planning technology can transform the health of your patients and practice.

About BrainCheck:
BrainCheck provides rapid, mobile cognitive assessment and decision support technology to physicians, empowering them to deliver high-quality, personalized cognitive health care to patients everywhere and get reimbursed. This helps patients live better and safer lives at home, decreases caregiver frustration, and saves health systems trillions. Founded in 2015 by neuroscientists and technologists Dr. David Eagleman (Baylor College of Medicine / Stanford) and Dr. Yael Katz, BrainCheck helps lessen the human and economic toll of cognitive impairment and dementia through its interactive cognitive assessment and care management technology. BrainCheck is used in over 50 clinical practices and by 40,000 people around the world to detect cognitive changes early and enable patients, caregivers, and clinicians to work together to implement personalized recommendations to preserve brain health and functional independence. BrainCheck enables physicians to get paid for cognitive care management (via Medicare reimbursement) and simultaneously reduces healthcare costs by keeping patients healthy, safe, and out of the hospital.

BrainCheck was recognized at the 2018 Society of General Internal Medicine Annual Meeting with the first place award for Innovation, for providing a much-needed and promising solution to the “silver tsunami.”

To learn more, please visit braincheck.com.

RxHealth logo

Rx.Health and BrainCheck Partner to Combat Mental Health Crisis


BrainCheck’s products will now be fully integrated onto Rx.Health’s RxUniverse Digital Medicine Prescribing Platform

HOUSTON (PRWEB) — OCTOBER 10, 2017
In recognition of World Mental Health Day and the importance of changing the Country’s narrative on mental health, Rx.Health and BrainCheck are proud to announce a strategic partnership focused on providing cognitive benefits to patients through digital therapeutics. World Mental Health Day was established in 1992 to advocate against the social stigma surrounding mental health issues and raise awareness of mental health education worldwide.

READ MORE

BrainCheck’s products will now be fully integrated onto Rx.Health’s RxUniverse Digital Medicine Prescribing Platform, which enables physicians to prescribe evidence-based mobile apps, multi-media education, wearables, and customized care plans for various diseases, procedures and surgeries at the point of care. BrainCheck’s digital technologies provide doctors and patients with a comprehensive understanding of the brain to assess brain performance with innovative neurocognitive testing.

“Through our partnership with Rx.Health, we are now able to reach thousands of patients and providers in healthcare systems around the world,” said Dr. Yael Katz, co-founder and CEO of BrainCheck. “This signals a substantial step toward delivering on our promise of making a cognitive health assessment a routine part of healthcare.”

Experts estimate that up to 40 percent of people with Alzheimer’s disease suffer from depression. Cognitive impairment and mental health conditions often go hand-in-glove, with depression leading to difficulty “thinking” and impaired cognition leading to depression. Because both cognitive and psychiatric conditions can lead to decreased quality of life, it is critical to assess cognitive function in all mental health patients.

BrainCheck was conceptualized and spun out of the Baylor College of Medicine, where co-founder Dr. David Eagleman pioneered the vision of empowering patients to take control of their cognitive health with intuitive, interactive assessments. Widely recognized as a visionary in the field of neuroscience for over 20 years, Dr. Eagleman is also a New York Times best-selling author, a TED speaker, and the creator and host of the Emmy-nominated PBS series “The Brain.” “You get a clear picture of your body’s health with a visit to the doctor, but no measure at all of your brain health,” said Eagleman. “BrainCheck allows people to get a clear picture of their cognitive function through time.”

“If you’ve got your toe in the water of Digital Medicine, you’re aware that the application of digital therapeutics to cognitive wellness is tremendous and absolutely necessary,” said Pavan Choksi, who heads corporate development at Rx.Health. “BrainCheck not only represents the gold standard in this space, but also shares a similar ethos with Rx.Health as a data-driven company born out of a top academic medical center.”

About Rx.Health: 
Rx.Health is defining the delivery of Digital Medicine. Formerly Responsive Health, a spinoff from the Mount Sinai Health System, Rx.Health is dedicated to facilitating the digital revolution in healthcare. Rx.Health’s flagship product, RxUniverse, is the first enterprise-based Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics to patients at the point of care. Information on Rx.Health and RxUniverse is available at hRx.Health and RxUniverse.com, or follow Rx.Health on Twitter @Rx_Health and LinkedIn at linkedin.com/company/Rx-Health.

About BrainCheck: 
BrainCheck’s goal is to democratize cognitive health by bringing its interactive testing platform to people everywhere. Available on iPhone, iPad and desktop, in English and Spanish, BrainCheck assesses multiple cognitive domains in minutes and delivers results that can be shared with family members, caregivers, and clinicians. BrainCheck is used by individuals, athletic teams, senior organizations, and doctors around the world, and is spreading rapidly. The platform also includes special content by renowned neuroscientist, author and speaker Dr. David Eagleman to give people insights into the inner workings of the brain and a better understanding of their brain health. To learn more, please visit braincheck.com.

True Wealth Ventures logo

BrainCheck Raises $1.5 Million in Additional Capital To Expand Healthcare Pipeline

HOUSTON (PRWEB) — MAY 31, 2017
BrainCheck, a mobile brain health tracking solution, announced today that it has completed a $1.5 million round of funding to deliver on its promise of bringing its innovative brain performance platform to people everywhere. Additional funding led by True Wealth Ventures and other contributors brings the total seed funding to $4.5 million since the company was founded in 2015.

READ MORE

This most recent round of funding will support BrainCheck as the company expands global sales and delivery across its multi-million dollar cognitive health pipeline. The company currently empowers 15,000 customers with its world-class brain health tracking solution including individuals, athletic teams, senior organizations, and doctors around the world.

BrainCheck is the result of 20 years of research conducted at the Eagleman Laboratory for Perception and Action at Baylor College of Medicine. As one of the few accessible cognitive health applications on the market, BrainCheck is positioned to change millions of lives by helping individuals better manage their overall brain health and recover from traumatic brain injuries.

“Our vision is to empower people everywhere to take control of their cognitive health by making our platform accessible, simple, and interactive. As a result of this funding, we are now able to accelerate our growth, expand our channels, and deliver on our promise of democratizing brain health,” said Dr. Yael Katz, Co-founder and CEO of BrainCheck. “Whether the concern is a head injury, memory loss, or cognitive impairment, we’re scaling our ability to deliver rapid and reliable cognitive health monitoring for families, caregivers, and clinicians to positively affect change and improve outcomes.”

Today only 2% of venture dollars go to women-led startups and 17% to those with a woman on the leadership team. “We’re thrilled that BrainCheck CEO, Dr. Yael Katz, is joining this community of venture-backed, women-led businesses who have historically received less investor attention. BrainCheck illustrates a massive opportunity to have more women driving healthcare innovation,” said Kerry Rupp, True Wealth Ventures’ General Partner.

Women’s health products and technologies represent an overlooked market opportunity due to the lack of women investors in venture capital. True Wealth Ventures believes there are clear advantages for companies with women on the management team to design products for, sell to, and service women’s healthcare needs. More women-led venture capital firms and women leaders targeting healthcare will bring greater opportunities to solve unaddressed patient needs.

BrainCheck occupies a unique position to deliver cognitive health solutions to the millions of women suffering from brain trauma and dementia. In sports such as soccer, concussions are 1.5 times more common in females than males, yet nearly all concussion research has been done on men. Of the estimated 5.5 million Americans living with Alzheimer’s, two-thirds of them are women. All while two-thirds of dementia caregivers are women.

In concussion research there is a need for women’s brains for study due to insufficient research into female concussions. Maria Carrillo, chief science officer for the Alzheimer’s Association, has called on researchers to address the gaps in our understanding of increased dementia risk in women. With its investment in BrainCheck, True Wealth Ventures is advancing solutions that help female patients, their families, and caretakers to quickly and proactively assess their brain health data with an affordable, convenient, and personalized solution.

“The accumulation of women impacted by cognitive health conditions, either directly or as primary caretakers, lends a clear advantage to women healthcare leaders to better serve the needs of today’s female patients,” said Kerry Rupp. “In the United States, women make over 80% of healthcare decisions for their families. Using BrainCheck to monitor their cognitive health, women and their families are more prepared to understand and track what is happening in their brain and act on that information.”

As part of the announcement, True Wealth Ventures’ General Partner, Kerry Rupp, will join BrainCheck’s Board of Directors. Other board members include Dr. Yael Katz, Dr. David Eagleman, Dr. George McLendon, and Daniel Cotlar.

About BrainCheck
BrainCheck’s goal is to democratize cognitive health by bringing its interactive testing platform to people everywhere. Available on iPhone, iPad and desktop, and in English and Spanish, BrainCheck assesses multiple cognitive domains in minutes and delivers results that can be shared with family members, caregivers, and clinicians. BrainCheck is used by individuals, athletic teams, senior organizations, and doctors around the world, and is spreading rapidly. The platform also includes special content by renowned neuroscientist, author and speaker Dr. David Eagleman to give people insights into the inner workings of the brain and a better understanding of their brain health. To learn more, please visit https://braincheck.com.

About True Wealth Ventures
True Wealth Ventures is a start-up venture capital fund for women with ideas to change the world. Founded by Sara Brand and Kerry Rupp, the fund focuses on women-led companies in the consumer health and sustainability sectors. Companies founded by women have consistently demonstrated stronger returns than the market but are still under-represented as a share of VC investments, and female founders are uniquely positioned to craft consumer propositions given that women make 85% of all household purchasing and 80% of healthcare decisions. True Wealth Ventures is one of a very small number of women-led early-stage VC funds in the country that is also focused on gender diverse teams, and the only one based in Texas. For more information, visit www.truewealthvc.com.

Health Museum Partners with David Eagleman’s BrainCheck, Bringing Cutting-edge Neuroscience and Technology to Its Guests

HOUSTON (PRWEB) — APRIL 24, 2017
The John P. McGovern Museum of Health and Medical Science is now partnered with BrainCheck, an innovative technology that allows anyone, anywhere to track their cognitive health, and share results with their physicians. Members and guests can sign up for its free edition to check their own brain health on the museum’s website.

READ MORE

BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and now at Stanford University, is one of the most famous faces of neuroscience, with his New York Times best-selling books and Emmy-nominated PBS Series “The Brain.” “With BrainCheck available through the museum, anyone can measure their brain health and gain insight into what’s happening under the hood,” Eagleman said.

The BrainCheck platform uses interactive neurocognitive tests to measure brain performance in multiple domains. The tests are fun and easy-to-use, with versions geared for both children and older adults.

Dr. Melanie Johnson, president and CEO of the Health Museum, spoke on the partnership and its benefits to the community, saying, “We are thrilled to be partnering with BrainCheck to offer our members and guests the opportunity to glean information about their brain health. David Eagleman has done such incredible work in the field of neurocognitive testing and we’re delighted that guests can log on to our website and start tracking their own brain health with a few simple steps. We believe that the future of health is intrinsically linked with technology and we are always on the lookout for partnerships that help us connect our members and guests with resources and information not previously available to them.”

To kick off the new partnership, the museum hosted “The Secret Lives of the Brain,” a special lecture with Dr. Eagleman. Later this year, the museum will feature an exhibit dedicated to BrainCheck so families can learn the importance of brain health and neuroscience and interact with the app on-site.

For more information or to sign up for the app, visit https://braincheck.com.

About BrainCheck
BrainCheck’s goal is to democratize cognitive health by bringing its interactive testing platform to people everywhere. Available on iPhone, iPad and desktop, and in English and Spanish, BrainCheck assesses multiple cognitive domains in minutes and delivers results that can be shared with family members, caregivers, and clinicians. BrainCheck is used by individuals, athletic teams, senior living organizations, and doctors around the world, and is spreading rapidly. The platform also includes special content by renowned neuroscientist, author and speaker Dr. David Eagleman to give people insights into the inner workings of the brain and a better understanding of their brain health. To learn more, please visit https://braincheck.com.

About the Health Museum
The Health Museum is committed to excellence in innovative and interactive health science experiences. The most interactive and popular science learning center of its kind, the museum inspires passion and curiosity in health, medical sciences, and the human body. The museum provides a variety of programs for adults and children alike. It is also home to the McGovern 4D Theater, “the Amazing Body Gallery,” and seasonal and traveling exhibits. The museum offers affordable memberships for individuals and families. To learn more, please visit http://www.thehealthmuseum.org.

CSMI

BrainCheck and SportsWareOnLine Deep Integration Helps Athletic Trainers Better Manage Student Brain Health

HOUSTON (PRWEB) — MARCH 27, 2017
Athletic trainers now have a better way to test, monitor and track the brain health of their athletes throughout the year or after an injury with one simple platform, thanks to BrainCheck’s end-to-end integration with CSMi’s SportsWareOnLine.

READ MORE

The partnership, which began in June 2016, has led to over 10,000 athletes currently using the joint platform.

“Building on our success, we have expanded our integration to include the ability to test athletes within the SportsWare system, where athletes’ results will automatically be added and tracked for athletic trainers and coaches to easily access,” said Yael Katz, CEO of BrainCheck. “We continue to add many sought-after features,” she added.

BrainCheck’s application uses interactive neurocognitive tests to measure athletes’ brain performance, allowing athletes to track changes over time.

“With SportsWare recording Sports Concussion Assessment Tool (SCAT3) and Vestibular/Ocular Motor Screening (VOMS) data, the partnership with BrainCheck and its neurocognitive assessment tools made perfect sense in our efforts to continually expand the concussion management solutions we offer our customers,” said Rich Potash, CEO of CSMi.

The pairing is the first integration of a mobile cognitive assessment platform with the SportsWare product, which is the leading athlete injury tracking system in the U.S., currently serving over 2.5 million student athletes.

About BrainCheck
BrainCheck is the result of 20 years of research conducted at the Eagleman Laboratory for Perception and Action at the Baylor College of Medicine. Dr. David Eagleman, BrainCheck founder and CSO, has been studying and creating reliable, noninvasive ways to understand the inner workings of the brain and assess brain function with innovative neurocognitive testing.

BrainCheck uses gold-standard neurocognitive tests and turns them into interactive mobile games to provide a simple approach to tracking brain health. BrainCheck is available on iPhone, iPad and desktop, and in English and Spanish. To learn more, please visit https://braincheck.com.

About CSMi
CSMi designs and manufactures computer-based measurement, training, and documentation solutions. CSMi’s product portfolio offers solutions for athletic trainers, physical therapists, and exercise scientists. Established in 1982, CSMi’s products are used in hospitals, clinics, athletic training rooms, research centers, industrial sites, and schools around the world. For more information, visit http://www.csmisolutions.com.